Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension

Journal of Human Hypertension volume 23, pages 668–673 (2009)Cite this article

Abstract

Resistin, a newly discovered protein, promotes endothelial dysfunction and proinflammatory activation, contributing to subclinical atherosclerosis in different clinical settings. In this study we sought to investigate the relationship of increased resistin levels with estimated glomerular filtration rate (eGFR), the most established marker of kidney impairment, in hypertensive subjects. Our population consisted of 132 untreated non-diabetic subjects with stage I–II essential hypertension (49 males, mean age=54 years, office blood pressure (BP)=159/100 mm Hg). In all patients eGFR was assessed by the Modification in Renal Disease equation and venous blood sampling was performed for estimation of resistin concentrations. The distribution of resistin was split by the median (4.63 ng ml−1) and accordingly subjects were stratified into those with high and low values. Hypertensive patients with high (n=66) compared to those with low resistin (n=66) exhibited lower eGFR values (77.1±9.4 vs 89.1±12.2 ml min−1 per 1.73m2, P<0.0001), even after adjustment for established confounders. In the total population, resistin was associated with 24-h systolic BP (r=0.244, P<0.05), serum creatinine (r=0.311, P=0.007) and eGFR (r=−0.519, P<0.0001). Multiple regression analysis revealed that age (b=0.379, P=0.01), body mass index (b=0.158, P=0.022), 24-h systolic BP (b=0.284, P=0.006) and resistin (b=0.429, P<0.0001) were independent predictors of eGFR (R2=0.436, P<0.0001). In essential hypertensive subjects, higher resistin levels are associated with renal function impairment, as reflected by decreased eGFR. Moreover, the independent association of resistin with eGFR suggests involvement of resistin in the progression of kidney damage in the early stages of hypertension.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Rangwala SM, Lazar ST, Bhat S, Brown EJ, Banerjee RR, Wright CM et al. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307–312.

    Article  Google Scholar 

  2. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 2003; 108: 736–740.

    Article  CAS  PubMed  Google Scholar 

  3. Steppan CM, Lazar MA . The current biology of resistin. J Intern Med 2004; 255: 439–447.

    Article  CAS  PubMed  Google Scholar 

  4. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ . Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003; 149: 331–335.

    Article  CAS  PubMed  Google Scholar 

  5. Norata GD, Ongari M, Garlaschelli K, Raselli S, Grigore L, Catapano AL . Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 2007; 156: 279–284.

    Article  CAS  PubMed  Google Scholar 

  6. Ohmori R, Momiyama Y, Kato R, Taniguchi H, Ogura M, Ayaori M et al. Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol 2005; 46: 379–380.

    Article  PubMed  Google Scholar 

  7. McTernan CL, McTernan PG, Harte AL, Levick PL, Barnett AH, Kumar S . Resistin, central obesity, and type 2 diabetes. Lancet 2002; 359: 46–47.

    Article  CAS  PubMed  Google Scholar 

  8. Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M . Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients. Transplant Proc 2006; 38: 3434–3436.

    Article  CAS  PubMed  Google Scholar 

  9. Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV et al. Resistin/Fizz3 expression in obesity and peroxisome proliferator- activated receptor y in humans. Diabetes 2001; 50: 2199–2202.

    Article  CAS  PubMed  Google Scholar 

  10. Zhang JL, Qin YW, Zheng X, Qiu JL, Zou DJ . Serum resistin level in essential hypertension patients with different glucose tolerance. Diabet Med 2003; 20: 828–831.

    Article  CAS  PubMed  Google Scholar 

  11. Furuhashi M, Ura N, Higashiura K, Murakami H, Shimamoto K . Circulating resistin levels in essential hypertension. Clin Endocrinol 2003; 59: 507–510.

    Article  CAS  Google Scholar 

  12. Takata Y, Osawa H, Kurata M, Kurokawa M, Yamauchi J, Ochi M et al. Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes. Hypertension 2008; 51: 534–539.

    Article  CAS  PubMed  Google Scholar 

  13. Shin HJ, Park S, Yoon SJ, Cho DK, Kim JS, Ko YG et al. Association between serum resistin and carotid intima media thickness in hypertension patients. Int J Cardiol 2008; 125: 79–84.

    Article  PubMed  Google Scholar 

  14. Axelsson J, Bergsten A, Qureshi AR, Heimbürger O, Bárány P, Lönnqvist F et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 2006; 69: 596–604.

    Article  CAS  PubMed  Google Scholar 

  15. Ellington AA, Malik AR, Klee GG, Turner ST, Rule AD, Mosley Jr TH et al. Association of plasma resistin with glomerular filtration rate and albuminuria in hypertensive adults. Hypertension 2007; 50: 708–714.

    Article  CAS  PubMed  Google Scholar 

  16. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. Management of Arterial Hypertension of the European Society of Hypertension et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105–1187.

    Article  CAS  PubMed  Google Scholar 

  17. Tsioufis C, Stefanadis C, Antoniadis D, Kallikazaros I, Zambaras P, Pitsavos C et al. Absence of any significant effects of circadian blood pressure variations on carotid artery elastic properties in essential hypertensive subjects. J Hum Hypertens 2000; 14: 813–818.

    Article  CAS  PubMed  Google Scholar 

  18. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39: S1–S246.

  19. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al. Recommendations for quantitation of the left ventricular dimensions by two-dimensional echocardiography. American Society of Echocardiography Committee on standards, subcommittee on quantitation of the two-dimensional echocardiograms. J Am Soc Echocardiogr 1989; 2: 358–367.

    Article  CAS  PubMed  Google Scholar 

  20. Kielstein JT, Becker B, Graf S, Brabant G, Haller H, Fliser D . Increased resistin blood levels are not associated with insulin resistance in patients with renal disease. Am J Kidney Dis 2003; 42: 62–66.

    Article  CAS  PubMed  Google Scholar 

  21. Risch L, Saely C, Hoefle G, Rein P, Langer P, Gouya G et al. Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function. Clin Chim Acta 2007; 376: 108–113.

    Article  CAS  PubMed  Google Scholar 

  22. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137–147.

    Article  PubMed  Google Scholar 

  23. Perticone F, Maio R, Tripepi G, Zoccali C . Endothelial dysfunction and mild renal insufficiency in essential hypertension. Circulation 2004; 110: 821–825.

    Article  CAS  PubMed  Google Scholar 

  24. Waldmann TA, Strober W, Mogienlnicki RP . The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome or uremia. J Clin Invest 1972; 51: 2162–2174.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Tsioufis C, Dimitriadis K, Chatzis D, Stougianos P, Kakavas A, Vlasseros I et al. Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardiol 2005; 96: 946–951.

    Article  CAS  PubMed  Google Scholar 

  26. Tsioufis C, Dimitriadis K, Taxiarchou E, Vasiliadou C, Charzoulakis G, Tousoulis D et al. Diverse associations of microalbuminuria with C-reactive protein, interleukin-18 and soluble CD 40 ligand in male essential hypertensive subjects. Am J Hypertens 2006; 19: 462–466.

    Article  CAS  PubMed  Google Scholar 

  27. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A . Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005; 174: 5789–5795.

    Article  CAS  PubMed  Google Scholar 

  28. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ . Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005; 111: 932–939.

    Article  CAS  PubMed  Google Scholar 

  29. Jung HS, Park KH, Cho YM, Chung SS, Cho HJ, Cho SY et al. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res 2006; 69: 76–85.

    Article  CAS  PubMed  Google Scholar 

  30. Verdecchia P, Schillaci G, Borgioni C, Giucci A, Pede S, Porcellati C . Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension 1998; 32: 983–988.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Cardiology Clinic, University of Athens, Hippokration Hospital, Athens, Greece

    K Dimitriadis, C Tsioufis, M Selima, D Tsiachris, A Miliou, A Kasiakogias, E Andrikou, D Tousoulis & C Stefanadis

Authors
  1. K Dimitriadis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Tsioufis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Selima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D Tsiachris
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Miliou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A Kasiakogias
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E Andrikou
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. D Tousoulis
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C Stefanadis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C Tsioufis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dimitriadis, K., Tsioufis, C., Selima, M. et al. Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension. J Hum Hypertens 23, 668–673 (2009). https://doi.org/10.1038/jhh.2009.12

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2009.12

Keywords

This article is cited by

Search

Advanced search

Quick links